Quinine, a naturally occurring alkaloid traditionally used for the treatment of malaria, is now most commonly used in this country for the relief of nocturnal muscle cramps. Acute poisoning induces a syndrome known as cinchonism and is usually seen after attempted abortion, suicide, or accidental poisoning in children.
Visual loss is one of the most common and important effects which has been well reported in the literature, but the site within the retina of the toxic effect and its management have been the subject of discussion and controversy since the turn of the century. We report a case of acute quinine poisoning as a suicidal attempt in a 47-year-old man and document the retinal changes, the pupillary findings, and the electrodiagnostic tests. There have been many reports over the last 20-30 years of the benefits of stellate ganglion block for the treatment of the ocular toxicity.
" Our patient was treated with a unilateral stellate ganglion block, and we discuss whether or not this treatment can be expected to have any beneficial effect. of the previous day. This was a genuine suicide attempt, but he had vomited prior to sleeping. He complained only of blindness.
When first seen he was generally well, though drowsy, his resting pulse rate being 60/minute, blood pressure 105/60 mmHg, and his electrocardiogram (ECG) showed sinus rhythm with normal electrical patterns. Routine blood tests, including full blood count, electrolyte tests, and liver function tests, were normal. Blood taken 18 to 24 hours after ingestion was sent to the Poisons Unit at Guy's Hospital for drug estimations. Quinine levels were 6.6 mg/l and desalkyl flurazepam 1-1 mg/l.
On admission an eye examination showed visual acuity to be limited to light perception in each eye, the pupils being equal, dilated, and fixed. The results of anterior segment examination and the intraocular pressures were normal. A fundal examination revealed bilateral generalised retinal oedema with bilateral macular cherry red spots, though the retinal vessels appeared normal.
Three hours later a right stellate ganglion block with 10 ml of 0.5% bupivacaine plus 1:100000 adrenaline was performed. There was no resultant subjective improvement, but a small right ptosis and right miosis were noted.
Subjective assessment of his visual recovery was hindered by functional overlay. On day 2 he claimed to see shadows only, but with a +0 5 dioptre correction he was persuaded to read nearly 6/5 with each eye. He was unable to see the reading text type book. There was minimal pupil reaction to light in the left eye and none on the right. Colour vision testing 219 rig. I uptic aisc ana macula of the left eye taken two aays after presentation (11 April 1984 5, 28 , and 30 weeks after quinine exposure, by infrared TV pupillography. On both sides the pupils were of normal appearance and diameter in the dark. There were bilateral defects to peripheral light perception, more severe on the right side, in keeping with the loss of peripheral vision. Light reflex responses to flash illumination were greatly reduced on both sides even when the light intensity was appropriately adjusted for the perception defect. The pupillary response to accommodation was reduced, and there was only a small sympathetic dilatation to loud noise.
At the second examination both pupils showed a small response to 2% phenylephrine eyedrops. At the third examination the mydriatic responses to tropicamide 0-5% alone and subsequently to tropicamide plus phenylephrine 10% were within normal limits.
These findings are suggestive of more than one site of involvement in the pupillary pathways. The reduced perception of light is consistent with an afferent defect of retinal or optic nerve origin, but the poor reflex responses also indicate an efferent defect, the site of which is uncertain. It could be neurological or originate in the iris muscle, but the normal response to the anticholinergic drug tropicamide makes a local iris muscle defect less likely. Alcoholic neuropathy might be an additional factor. Our patient had the typical ocular changes of acute quinine poisoning. Although he had taken a combination of quinine and flurazepam, no visual toxicity has been associated with the latter. He was seen 18-24 hours after the initial overdose with a moderately large amount of the drug, though the effects of the overdose might have been ameliorated by vomiting. Nevertheless blood levels were moderately high (6.6 mg/l) at this stage. His pupils were fixed and dilated, acuity was limited to perception of light, and funduscopy showed inner retinal oedema with normal retinal vessel calibre (Fig. 1) . The visual acuity and field defects rapidly improved (Fig. 3) and his pupils reduced to normal size over about three weeks. Retinal arterial constriction and optic disc pallor were observed to begin about three weeks later with visual field improvement (Fig. 2) .
Pupillary dilatation is a consistent feature of acute quinine poisoning, both in humans and experimental animals. It must indicate either a neurological efferent pathway defect or local sphincter paralysis. In some patients the pupillary changes may be so extreme that the patient is left with dilated atrophic pupils.9 The precise site of this lesion is obscure, but the response of an induced Horner's syndrome to stellate ganglion block in our and other patients must indicate that the sphincter still retains some contractile power. Formal pupillometry on our patient was not carried out until the acute stages were passed and may also have been complicated by the possibility of an alcoholic autonomic neuropathy. Apart from confirming the presence of both afferent and efferent pupillary defects, we were unable to elucidate the nature of the efferent defect any further at this time. Gangitano and Keltner"' reported on a patient with quinine toxicity who developed tonic pupillary responses seven months after ingestion. It is not completely clear whether the development of Adie'slike pupils in this report was directly related to quinine toxicity or could have been coincidental. While our patient was not tested for supersensitivity to pilocarpine, the pupillary reflexes were not tonic at I or 7 months, which effectively excludes an Adie'slike pupil.
The electrophysiology on our patient was performed four weeks after the overdose, and the findings of a reduced EOG, loss of the b wave in the ERG, and reduced flicker fusion are in general agreement with the experience of others when these patients were examined in the chronic stage of their illness."" The initial changes in the electrophysiology are controversial and there is a voluminous continental literature on the electrophysiological changes found with quinine toxicity."' Some authors have found normal ERGs in the acute phase, but a careful study of an acute case showed that in the earliest stages there was increased a wave amplitude and decreased b wave with a low EOG. " Within three days the ERG approached normal values, but by the ninth day the b wave had started to decrease and six months later remained essentially unchanged. These findings were corroborated in rabbit experiments,' and the authors" '4 suggest that these results imply a direct early toxic effect of quinine on the neuroretina.
Successful treatment of the visual loss from quinine depends on a knowledge of the mechanism of toxicity and its localisation in the retina. Accurate information on both these aspects is lacking as little experimental work has been done in recent years. The possibilities are that the retinal changes are due to either arterial vasocOnstriction and inner retinal ischaemia or to a direct toxicity of the neuroretina, and these alternatives have been debated since the 1890s without conclusive evidence being obtained for either hypothesis. The fundal appearances simulate a central retinal artery occlusion, but a review of previous reports is confusing on whether the retinal arteries are constricted in the earliest phases. Our patient had inner retinal oedema with normal retinal vessels ( Fig. 1) 18-24 hours after overdose, though it is conceivable, but unlikely, that the retinal vessels may have been constricted and dilated again before presentation. Optic disc pallor and retinal vascular attenuation were noted by three weeks after the overdose. The natural history of the toxicity, however, with return of good visual acuity, peripheral constriction of the field, arterial attenuation, and optic atrophy is quite different from that occasionally seen with visual recovery following central retinal arterial occlusion, and this therefore supports the neural toxicity theory. Retinal toxicity also tends to be supported by the electrophysiological evidence already mentioned. There are no adequate reports of the pathology of quinine poisoning in man, though two appear to have been the first to use it in humans.' Since then there have been numerous enthusiastic reports of its efficacy, which are surprising in view of the lack of a sympathetic innervation of the retinal vessels or evidence to suggest that quinine toxicity produces spasm of the ophthalmic artery or other arteries elsewhere. In'our patient a unilateral sympathetic blockade did not offer any therapeutic advantage to that eye. Although permanent blindness may result from quinine toxicity, there is a natural tendency to improvement, and critical review of many reported cases does not give support for any consistent therapeutic effect (Table 1) . Although patients were left with good central visual acuity and constricted fields, there does not appear to be any consistent relationship between the amount of drug ingested and the time of stellate ganglion block and visual recovery. Similar visual recovery has been reported in cases without stellate block.9"" 12 22 This procedure is not without hazard, potential complications being intra-arterial injection, pneumothorax, or paralysis of the diaphragm or vocal cords by pharyngeal or recurrent laryngeal nerve palsy.
Stellate ganglion blockade therefore appears unlikely to be justified in the management of visual loss from quinine toxicity, which agrees with the experience of Dyson et al.,27 who reviewed 48 patients with quinine poisoning, six of whom had visual problems. They found that those patients with the highest blood levels (related to time of ingestion) were most likely to have ocular change. Stellate ganglion block appeared to be ineffective.
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